- Home
- HITI vs SCPH Comparison
HITI vs SCPH Comparison
Compare HITI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- SCPH
- Stock Information
- Founded
- HITI 2009
- SCPH 2013
- Country
- HITI Canada
- SCPH United States
- Employees
- HITI N/A
- SCPH N/A
- Industry
- HITI
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- HITI
- SCPH Health Care
- Exchange
- HITI Nasdaq
- SCPH Nasdaq
- Market Cap
- HITI 249.3M
- SCPH 179.6M
- IPO Year
- HITI N/A
- SCPH 2017
- Fundamental
- Price
- HITI $3.09
- SCPH $3.28
- Analyst Decision
- HITI Strong Buy
- SCPH Strong Buy
- Analyst Count
- HITI 1
- SCPH 2
- Target Price
- HITI $4.50
- SCPH $15.00
- AVG Volume (30 Days)
- HITI 641.5K
- SCPH 426.6K
- Earning Date
- HITI 03-14-2025
- SCPH 03-12-2025
- Dividend Yield
- HITI N/A
- SCPH N/A
- EPS Growth
- HITI N/A
- SCPH N/A
- EPS
- HITI N/A
- SCPH N/A
- Revenue
- HITI $370,017,302.00
- SCPH $30,278,000.00
- Revenue This Year
- HITI $7.52
- SCPH $172.64
- Revenue Next Year
- HITI $14.03
- SCPH $131.43
- P/E Ratio
- HITI N/A
- SCPH N/A
- Revenue Growth
- HITI 9.02
- SCPH 303.87
- 52 Week Low
- HITI $1.57
- SCPH $3.08
- 52 Week High
- HITI $3.62
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- HITI 48.76
- SCPH 41.49
- Support Level
- HITI $3.01
- SCPH $3.27
- Resistance Level
- HITI $3.23
- SCPH $3.59
- Average True Range (ATR)
- HITI 0.15
- SCPH 0.19
- MACD
- HITI -0.02
- SCPH -0.00
- Stochastic Oscillator
- HITI 32.14
- SCPH 2.08
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically-integrated company in the Canadian cannabis market with portfolio subsidiaries including RGR Canada Inc., Famous Brandz Inc., Kush West Distribution Inc., Smoker's Corner Ltd., Grasscity.com, Canna Cabana Inc., and KushBar Inc. The firm has established two main segments, retail and wholesale. It generates substantial revenue from retail stores' e-commerce platforms. Geographically it serves Canada, the USA, and other international markets and earns key revenue from domestic sales.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.